Clinical Trial Update: Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 single-dose study evaluating the pharmacokinetics, safety/tolerability, and QTc effects of GSK1278863 in healthy volunteers, with anemia listed as the r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• GSK1278863

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 1 | Status: COMPLETED